​

Glaukos (GKOS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

GKOS Stock Forecast

Glaukos stock forecast is as follows: an average price target of $144.14 (represents a -4.47% downside from GKOS’s last price of $150.88) and a rating consensus of 'Buy', based on 21 wall street analysts offering a 1-year stock forecast.

GKOS Price Target

The average price target for Glaukos (GKOS) is $144.14 based on 1-year price targets from 21 Wall Street analysts in the past 3 months, with a price target range of $155.00 to $120.00. This represents a potential -4.47% downside from GKOS's last price of $150.88.

GKOS Analyst Ratings

Buy

According to 21 Wall Street analysts, Glaukos's rating consensus is 'Buy'. The analyst rating breakdown for GKOS stock is 0 'Strong Buy' (0.00%), 16 'Buy' (76.19%), 4 'Hold' (19.05%), 1 'Sell' (4.76%), and 0 'Strong Sell' (0.00%).

Glaukos Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 02, 2024Thomas StephanStifel Nicolaus$153.00$140.189.14%1.41%
Dec 02, 2024Patrick WoodMorgan Stanley$120.00$140.80-14.77%-20.47%
Nov 05, 2024David SaxonNeedham$149.00$127.4516.91%-1.25%
Nov 05, 2024Ryan ZimmermanBTIG$140.00$127.869.49%-7.21%
Oct 29, 2024Michael SarconeJefferies$155.00$134.0815.60%2.73%
Oct 21, 2024Samuel BrodovskyTruist Financial$152.00$132.8714.40%0.74%
Oct 17, 2024Matt O'BrienPiper Sandler$140.00$128.209.20%-7.21%
Sep 23, 2024Ryan ZimmermanBTIG$139.00$127.788.78%-7.87%
Sep 03, 2024Thomas StephanStifel Nicolaus$145.00$134.527.79%-3.90%
Jun 05, 2024Thomas StephanStifel Nicolaus$130.00$111.6316.46%-13.84%
Jun 03, 2024Larry BiegelsenWells Fargo$120.00$112.726.46%-20.47%
May 28, 2024Samuel BrodovskyTruist Financial$125.00$108.8914.79%-17.15%
May 21, 2024Matt O'BrienPiper Sandler$110.00$107.941.91%-27.09%
May 06, 2024Michael SarconeJefferies$125.00$106.5117.36%-17.15%
May 02, 2024David SaxonNeedham$113.00$98.9114.25%-25.11%
Dec 28, 2022Stephens$68.00$41.2864.73%-54.93%
Dec 19, 2022J.P. Morgan$42.00$42.48-1.13%-72.16%
Apr 21, 2022Ryan ZimmermanBTIG$66.00$61.267.74%-56.26%

The latest Glaukos stock forecast, released on Dec 02, 2024 by Thomas Stephan from Stifel Nicolaus, set a price target of $153.00, which represents a 9.14% increase from the stock price at the time of the forecast ($140.18), and a 1.41% increase from GKOS last price ($150.88).

Glaukos Price Target by Period

1M3M12M
# Anlaysts2815
Avg Price Target$136.50$143.50$134.40
Last Closing Price$150.88$150.88$150.88
Upside/Downside-9.53%-4.89%-10.92%

In the current month, the average price target of Glaukos stock is $136.50, according to 2 Wall Street analysts offering twelve months forecast. The average price target represents a -9.53% decrease as opposed to Glaukos's last price of $150.88. This month's average price target is down -4.88% compared to last quarter, and up 1.56% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Dec 11, 2024CitigroupBuyBuyUpgrade
Dec 02, 2024Morgan StanleyEqual-WeightUnderweightDowngrade
Oct 29, 2024JefferiesBuyBuyHold
Oct 17, 2024Piper SandlerOverweightOverweightHold
Sep 23, 2024BTIGBuyBuyHold
Aug 28, 2024BTIGBuyBuyHold
Jul 15, 2024Morgan StanleyEqual-WeightEqual-WeightHold
May 22, 2024Wells FargoBuyBuyHold
May 22, 2024Truist FinancialUnderperformUnderperformHold
May 22, 2024CitigroupBuyBuyHold
May 21, 2024Piper SandlerOverweightOverweightHold
May 06, 2024JefferiesBuyUpgrade
May 02, 2024Wells FargoOverweightOverweightHold
May 02, 2024NeedhamBuyBuyHold
Apr 15, 2024BTIGBuyBuyHold
Mar 22, 2024Wells FargoBuyBuyHold
Feb 16, 2024Truist FinancialBuyBuyHold
Dec 21, 2023J.P. MorganOverweightUpgrade
Dec 21, 2023Morgan StanleyOverweightUpgrade
Dec 21, 2023Wells FargoBuyBuyHold
Dec 15, 2023William BlairOutperformOutperformHold
Nov 08, 2023Wells FargoOverweightUpgrade
Jul 19, 2023NeedhamBuyBuyHold
Jun 07, 2023BenchmarkHoldInitialise
Jun 07, 2023Piper SandlerOverweightUpgrade
Feb 23, 2023CitigroupBuyBuyHold
Dec 28, 2022StephensOverweightOverweightHold
Dec 22, 2022Evercore ISIOutperformInitialise
Dec 22, 2022Loop Capital MarketsBuyInitialise
Dec 22, 2022Janney MontgomeryBuyInitialise
Dec 22, 2022ScotiabankSector PerformInitialise
Dec 22, 2022Cantor FitzgeraldOverweightInitialise
Dec 22, 2022EF HuttonBuyInitialise
Dec 22, 2022WedbushOutperformInitialise
Dec 22, 2022RBC CapitalOutperformInitialise
Dec 19, 2022MoffettNathansonMarket PerformUpgrade
Dec 19, 2022UBSNeutralInitialise
Oct 04, 2022NeedhamBuyInitialise
May 17, 2022CitigroupBuyBuyHold
Apr 21, 2022BTIGBuyBuyHold
Feb 23, 2022CitigroupNeutralNeutralHold

Glaukos's last stock rating was published by Citigroup on Dec 11, 2024. The company gave GKOS a "Buy" rating, the same as its previous rate.

Glaukos Financial Forecast

Glaukos Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue-------------$78.05M$80.40M$73.90M$71.23M$71.27M$72.69M$67.68M$73.24M$74.71M$78.09M$67.97M$73.23M$64.83M$31.56M$55.34M$65.85M$58.51M
Avg Forecast$183.11M$155.36M$156.50M$134.47M$129.44M$120.91M$117.35M$105.53M$100.53M$91.50M$88.86M$79.60M$81.00M$75.25M$74.73M$67.59M$68.07M$67.96M$67.99M$60.85M$67.28M$72.73M$71.32M$65.01M$68.31M$53.74M$20.39M$57.89M$62.98M$56.96M
High Forecast$189.25M$160.58M$161.75M$138.99M$133.78M$124.97M$121.29M$107.78M$100.94M$91.50M$88.86M$79.60M$81.17M$76.86M$77.23M$69.86M$70.36M$67.96M$67.99M$60.85M$67.28M$72.73M$71.32M$65.01M$68.31M$53.74M$20.39M$57.89M$62.98M$56.96M
Low Forecast$174.99M$148.47M$149.56M$128.51M$123.70M$115.55M$112.15M$102.26M$99.78M$91.49M$88.86M$79.60M$80.92M$73.40M$71.41M$64.60M$65.05M$67.96M$67.99M$60.85M$67.28M$72.73M$71.32M$65.01M$68.31M$53.74M$20.39M$57.89M$62.98M$56.96M
# Analysts334545271152241159544755107599955
Surprise %-------------1.04%1.08%1.09%1.05%1.05%1.07%1.11%1.09%1.03%1.09%1.05%1.07%1.21%1.55%0.96%1.05%1.03%

Glaukos's average Quarter revenue forecast for Dec 23 based on 4 analysts is $81.00M, with a low forecast of $80.92M, and a high forecast of $81.17M. GKOS's average Quarter revenue forecast represents a 3.78% increase compared to the company's last Quarter revenue of $78.05M (Sep 23).

Glaukos EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts334545271152241159544755107599955
EBITDA-------------$-28.01M$-29.07M$-21.48M$-27.75M$-23.85M$-42.23M$-12.00M$-10.07M$18.47M$-5.46M$-4.41M$535.00K$-2.31M$-36.81M$-45.01M$-23.95M$-10.34M
Avg Forecast$-35.47M$-30.10M$-30.32M$-26.05M$-25.07M$-23.42M$-22.73M$-20.44M$-19.47M$-17.72M$-17.21M$27.01M$-15.69M$-14.58M$-14.48M$24.55M$-12.87M$-21.49M$-21.50M$22.32M$-21.27M$-23.00M$-22.55M$-4.96M$-21.60M$-16.99M$-6.45M$-39.24M$-19.91M$-18.01M
High Forecast$-33.90M$-28.76M$-28.97M$-24.89M$-23.96M$-22.38M$-21.72M$-19.81M$-19.33M$-17.72M$-17.21M$32.41M$-15.68M$-14.22M$-13.83M$29.46M$-10.30M$-21.49M$-21.50M$26.78M$-21.27M$-23.00M$-22.55M$-3.97M$-21.60M$-16.99M$-6.45M$-31.39M$-19.91M$-18.01M
Low Forecast$-36.66M$-31.11M$-31.33M$-26.92M$-25.92M$-24.21M$-23.50M$-20.88M$-19.55M$-17.73M$-17.21M$21.61M$-15.72M$-14.89M$-14.96M$19.64M$-15.44M$-21.49M$-21.50M$17.86M$-21.27M$-23.00M$-22.55M$-5.96M$-21.60M$-16.99M$-6.45M$-47.08M$-19.91M$-18.01M
Surprise %-------------1.92%2.01%-0.87%2.16%1.11%1.96%-0.54%0.47%-0.80%0.24%0.89%-0.02%0.14%5.71%1.15%1.20%0.57%

5 analysts predict GKOS's average Quarter EBITDA for Dec 21 to be $-21.27M, with a high of $-21.27M and a low of $-21.27M. This is -215.19% lower than Glaukos's previous annual EBITDA (Sep 21) of $18.47M.

Glaukos Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts334545271152241159544755107599955
Net Income-------------$-30.44M$-32.81M$-34.63M$-31.46M$-27.58M$-45.54M$5.38M$-21.87M$6.23M$-17.48M$-16.47M$-10.65M$-15.75M$-39.89M$-54.06M$36.58M$-13.51M
Avg Forecast$2.77M$3.09M$-834.20K$200.50K$-13.09M$-13.98M$-15.78M$-19.82M$-20.67M$-26.29M$-28.36M$8.07M$-30.23M$-30.28M$-30.57M$7.33M$-27.96M$-26.49M$-22.21M$6.67M$-18.91M$-12.34M$-12.48M$-18.53M$-14.79M$-24.75M$-38.77M$-47.13M$-8.37M$-8.17M
High Forecast$2.90M$3.22M$-786.11K$209.25K$-12.33M$-13.17M$-14.87M$-16.90M$-16.34M$-24.78M$-26.73M$9.68M$-26.99M$-28.63M$-28.81M$8.80M$-22.37M$-26.49M$-22.21M$8.00M$-18.91M$-12.34M$-12.48M$-14.82M$-14.79M$-24.75M$-38.77M$-37.70M$-8.37M$-8.17M
Low Forecast$2.61M$2.91M$-870.59K$188.94K$-13.66M$-14.59M$-16.47M$-20.98M$-28.84M$-27.44M$-29.60M$6.45M$-32.39M$-33.59M$-31.90M$5.87M$-33.55M$-26.49M$-22.21M$5.33M$-18.91M$-12.34M$-12.48M$-22.23M$-14.79M$-24.75M$-38.77M$-56.55M$-8.37M$-8.17M
Surprise %-------------1.01%1.07%-4.72%1.13%1.04%2.05%0.81%1.16%-0.50%1.40%0.89%0.72%0.64%1.03%1.15%-4.37%1.65%

Glaukos's average Quarter net income forecast for Jun 22 is $-22.21M, with a range of $-22.21M to $-22.21M. GKOS's average Quarter net income forecast represents a -513.14% decrease compared to the company's last Quarter net income of $5.38M (Mar 22).

Glaukos SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts334545271152241159544755107599955
SG&A-------------$54.25M$53.14M$53.65M$51.93M$47.15M$49.90M$43.95M$47.57M$44.47M$45.30M$41.92M$43.79M$38.95M$38.12M$50.55M$59.61M$44.44M
Avg Forecast$128.58M$109.10M$109.90M$94.43M$90.89M$84.90M$82.40M$74.10M$70.59M$64.25M$62.40M$65.94M$56.88M$52.84M$52.47M$59.95M$60.81M$47.72M$47.74M$54.50M$47.24M$51.07M$50.08M$47.16M$47.96M$37.74M$14.32M$44.07M$44.23M$40.00M
High Forecast$132.89M$112.76M$113.58M$97.60M$93.94M$87.75M$85.17M$75.69M$70.88M$64.25M$62.40M$79.13M$57.00M$53.97M$54.23M$71.94M$72.97M$47.72M$47.74M$65.40M$47.24M$51.07M$50.08M$56.59M$47.96M$37.74M$14.32M$52.88M$44.23M$40.00M
Low Forecast$122.88M$104.26M$105.02M$90.24M$86.86M$81.14M$78.75M$71.80M$70.07M$64.24M$62.40M$52.75M$56.82M$51.54M$50.15M$47.96M$48.65M$47.72M$47.74M$43.60M$47.24M$51.07M$50.08M$37.73M$47.96M$37.74M$14.32M$35.25M$44.23M$40.00M
Surprise %-------------1.03%1.01%0.89%0.85%0.99%1.05%0.81%1.01%0.87%0.90%0.89%0.91%1.03%2.66%1.15%1.35%1.11%

Glaukos's average Quarter SG&A projection for Dec 23 is $56.88M, based on 4 Wall Street analysts, with a range of $56.82M to $57.00M. The forecast indicates a 4.85% rise compared to GKOS last annual SG&A of $54.25M (Sep 23).

Glaukos EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts334545271152241159544755107599955
EPS-------------$-0.63$-0.68$-0.72$-0.66$-0.58$-0.96$0.11$-0.47$0.13$-0.38$-0.36$-0.24$-0.35$-0.90$-1.24$0.92$-0.37
Avg Forecast$0.05$0.06$-0.02-$-0.24$-0.25$-0.29$-0.36$-0.38$-0.48$-0.52$-0.58$-0.55$-0.55$-0.56$-0.58$-0.55$-0.52$-0.44$-0.51$-0.37$-0.24$-0.25$-0.31$-0.29$-0.49$-0.76$-0.38$-0.17$-0.16
High Forecast$0.05$0.06$-0.01-$-0.22$-0.24$-0.27$-0.31$-0.30$-0.45$-0.49$-0.54$-0.49$-0.52$-0.52$-0.54$-0.51$-0.52$-0.44$-0.51$-0.37$-0.24$-0.25$-0.31$-0.29$-0.49$-0.76$-0.38$-0.17$-0.16
Low Forecast$0.05$0.05$-0.02-$-0.25$-0.27$-0.30$-0.38$-0.52$-0.50$-0.54$-0.60$-0.59$-0.61$-0.58$-0.60$-0.57$-0.52$-0.44$-0.51$-0.37$-0.24$-0.25$-0.31$-0.29$-0.49$-0.76$-0.38$-0.17$-0.16
Surprise %-------------1.15%1.22%1.25%1.21%1.11%2.19%-0.22%1.26%-0.53%1.54%1.18%0.82%0.72%1.18%3.28%-5.58%2.30%

According to 4 Wall Street analysts, Glaukos's projected average Quarter EPS for Jun 22 is $-0.44, with a low estimate of $-0.44 and a high estimate of $-0.44. This represents a -498.21% decrease compared to GKOS previous annual EPS of $0.11 (Mar 22).

Glaukos Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
SGHTSight Sciences$3.62$7.50107.18%Hold
KIDSOrthoPediatrics$22.46$39.5075.87%Buy
NVRONevro$4.05$5.8444.20%Hold
LIVNLivaNova$49.94$68.2536.66%Buy
BRKRBruker$57.81$79.0036.65%Buy
CNMDCONMED$71.23$97.0036.18%Buy
OFIXOrthofix Medical$17.93$24.0033.85%
IRMDIRadimed$53.00$60.0013.21%Buy
ITGRInteger$136.68$153.5012.31%Buy
FNAParagon 28$10.36$11.5011.00%Buy
SRDXSurmodics$39.96$39.50-1.15%Buy
GKOSGlaukos$146.35$144.14-1.51%Buy

GKOS Forecast FAQ

Is Glaukos a good buy?

Yes, according to 21 Wall Street analysts, Glaukos (GKOS) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 16 'Buy' recommendations, accounting for 76.19% of GKOS's total ratings.

What is GKOS's price target?

Glaukos (GKOS) average price target is $144.14 with a range of $120 to $155, implying a -4.47% from its last price of $150.88. The data is based on 21 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Glaukos stock go up soon?

According to Wall Street analysts' prediction for GKOS stock, the company can go down by -4.47% (from the last price of $150.88 to the average price target of $144.14), up by 2.73% based on the highest stock price target, and down by -20.47% based on the lowest stock price target.

Can Glaukos stock reach $200?

GKOS's average twelve months analyst stock price target of $144.14 does not support the claim that Glaukos can reach $200 in the near future.

What is Glaukos's current price target trend?

2 Wall Street analysts forecast a $136.5 price target for Glaukos (GKOS) this month, down -9.53% from its last price of $150.88. Compared to the last 3 and 12 months, the average price target decreased by -4.89% and decreased by -10.92%, respectively.

What are Glaukos's analysts' financial forecasts?

Glaukos's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $473.23M (high $487.82M, low $453.65M), average EBITDA is $-91.672M (high $-87.88M, low $-94.499M), average net income is $-62.655M (high $-57.272M, low $-65.69M), average SG&A $332.3M (high $342.55M, low $318.55M), and average EPS is $-1.138 (high $-1.041, low $-1.194). GKOS's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $629.45M (high $650.57M, low $601.54M), average EBITDA is $-122M (high $-117M, low $-126M), average net income is $5.23M (high $5.54M, low $4.84M), average SG&A $442M (high $456.83M, low $422.4M), and average EPS is $0.095 (high $0.101, low $0.088).

Did the GKOS's actual financial results beat the analysts' financial forecasts?

Based on Glaukos's last annual report (Dec 2022), the company's revenue was $282.86M, beating the average analysts forecast of $264.88M by 6.79%. Apple's EBITDA was $-105M, beating the average prediction of $-33.537M by 212.22%. The company's net income was $-99.195M, beating the average estimation of $-70.001M by 41.70%. Apple's SG&A was $192.92M, missing the average forecast of $210.77M by -8.47%. Lastly, the company's EPS was $-2.09, beating the average prediction of $-2.011 by 3.91%. In terms of the last quarterly report (Sep 2023), Glaukos's revenue was $78.05M, beating the average analysts' forecast of $75.25M by 3.72%. The company's EBITDA was $-28.01M, beating the average prediction of $-14.577M by 92.16%. Glaukos's net income was $-30.444M, beating the average estimation of $-30.282M by 0.54%. The company's SG&A was $54.25M, beating the average forecast of $52.84M by 2.67%. Lastly, the company's EPS was $-0.63, beating the average prediction of $-0.55 by 14.50%